Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Isoamyl 4-methoxycinnamate, Isopentyl p-methoxycinnamate, Amiloxate [usan], Isoamyl methoxycinnamate, Amiloxato, Nsc-408332
Molecular Formula
C15H20O3
Molecular Weight
248.32  g/mol
InChI Key
UBNYRXMKIIGMKK-RMKNXTFCSA-N
FDA UNII
376KTP06K8

AMILOXATE is a small molecule drug with a maximum clinical trial phase of II.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-methylbutyl (E)-3-(4-methoxyphenyl)prop-2-enoate
2.1.2 InChI
InChI=1S/C15H20O3/c1-12(2)10-11-18-15(16)9-6-13-4-7-14(17-3)8-5-13/h4-9,12H,10-11H2,1-3H3/b9-6+
2.1.3 InChI Key
UBNYRXMKIIGMKK-RMKNXTFCSA-N
2.2 Other Identifiers
2.2.1 UNII
376KTP06K8
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Isoamyl 4-methoxycinnamate

2. Isopentyl P-methoxycinnamate

3. Amiloxate [usan]

4. Isoamyl Methoxycinnamate

5. Amiloxato

6. Nsc-408332

7. 376ktp06k8

8. Amiloxate [inn]

9. Amiloxate [mi]

10. E-1000

11. 4-methoxycinnamic Acid, Isoamyl Ester

12. Amiloxate [mart.]

13. Amiloxate [usp-rs]

14. Amiloxate [who-dd]

15. Amiloxate [usp Impurity]

16. Dtxcid9026055

17. Dtxsid1046055

18. Amiloxate [usp Monograph]

19. Nsc408332

20. Amiloxate (mart.)

21. Amiloxate (usp-rs)

22. 3-methylbutyl (2e)-3-(4-methoxyphenyl)prop-2-enoate

23. Amiloxate (usp Impurity)

24. Amiloxate (usp Monograph)

25. Amiloxatum

26. Refchem:557171

27. 2-propenoic Acid, 3-(4-methoxyphenyl)-, 3-methylbutyl Ester

28. Isopentyl 3-(4-methoxyphenyl)acrylate

29. Isopentyl-4-methoxycinnamate

30. Isopentyl 4-methoxycinnamate

31. Isoamyl-p-methoxycinnamate

32. 155339-66-5

33. 3-methylbutyl (e)-3-(4-methoxyphenyl)prop-2-enoate

34. Mfcd00583856

35. Ncgc00159435-02

36. 3-(4-methoxyphenyl)-2-propenoic Acid, 3-methylbutyl Ester

37. (e)-isopentyl 3-(4-methoxyphenyl)acrylate

38. 3-methylbutyl 3-(4-methoxyphenyl)prop-2-enoate

39. Neo Heliopan E1000

40. Amiloxate [usan:usp:inn]

41. Unii-376ktp06k8

42. Einecs 275-702-5

43. Neo Heliopan (tn)

44. Brn 3132627

45. Amiloxate (usp/inn)

46. Ai3-05552

47. 96% (isomers Mixture)

48. E 1000

49. Ec 275-702-5

50. 3-methylbutyl 3-(4-methoxyphenyl)-2-propenoate

51. Schembl15764

52. 3-10-00-00850 (beilstein Handbook Reference)

53. Chembl1476782

54. 3-(4-methoxyphenyl)-2-propenoic Acid 3-methylbutyl Ester

55. Msk3423

56. Chebi:135982

57. Ubnyrxmkiigmkk-rmknxtfcsa-n

58. Dtxsid301349309

59. 4-methoxycinnamic Acid-isoamyl Ester

60. Tox21_111666

61. S3218

62. Akos015913998

63. Akos025310783

64. Cs-w012670

65. Db11207

66. Fi29838

67. Hy-w011954

68. Nsc 408332

69. Ncgc00159435-03

70. Bs-49548

71. Da-54393

72. Cas-71617-10-2

73. D02904

74. D91203

75. Isoamyl 4-methoxycinnamate, Analytical Standard

76. Sbi-0654197.0001

77. En300-7363198

78. Isopentyl (e)-3-(4-methoxyphenyl)prop-2-enoate

79. 617i102

80. En300-18004835

81. Sr-01000201509

82. Sr-01000201509-1

83. 3-(4-methoxyphenyl)-2-propenoic Acid, Isoamyl Ester

84. 3-methylbutyl (2e)-3-(4-methoxyphenyl)-2-propenoate

85. Brd-k37851352-001-01-0

86. Q17012246

87. Z212714982

88. Amiloxate, United States Pharmacopeia (usp) Reference Standard

89. 2-benzoic Acid, 2-propenoic Acid, 3-(4-methoxyphenyl)-3-methylbutyl Ester

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 248.32 g/mol
Molecular Formula C15H20O3
XLogP33.9
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count7
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area35.5
Heavy Atom Count18
Formal Charge0
Complexity263
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Indicated as an active sunscreen agent.


5 Pharmacology and Biochemistry
5.1 Absorption, Distribution and Excretion

Absorption

According to _in vitro_ studies of amiloxate-containing tape strips on porcine ear, there was no detection of amiloxate undergoing skin penetration.


Route of Elimination

No pharmacokinetic data available.


Volume of Distribution

No pharmacokinetic data available.


Clearance

No pharmacokinetic data available.


5.2 Metabolism/Metabolites

No pharmacokinetic data available.


5.3 Biological Half-Life

No pharmacokinetic data available.


5.4 Mechanism of Action

Amiloxate is a UV-B filter that selectively absorbs UV-B rays. It is proposed that amiloxate mediates an antioxidant action by acting as a free radical scavenger.